We are live on ! Find out more
VCYT icon

Veracyte

278 hedge funds and large institutions have $2.31B invested in Veracyte in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 102 increasing their positions, 103 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.34% more ownership

Funds ownership: 108.68%109.03% (+0.34%)

1% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 103

3% less funds holding

Funds holding: 287278 (-9)

8% less capital invested

Capital invested by funds: $2.51B → $2.31B (-$204M)

16% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 43

91% less call options, than puts

Call options by funds: $48K | Put options by funds: $513K

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
278
Holders Change
-9
Holders Change %
-3.14%
% of All Funds
3.66%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
36
Increased
102
Reduced
103
Closed
43
Calls
$48K
Puts
$513K
Net Calls
-$465K
Net Calls Change
-$423K
Name Holding Trade Value Shares
Change
Change in
Stake
Stifel Financial
126
Stifel Financial
Missouri
$884K +$620K +21,407 +190%
IIM
127
INTECH Investment Management
Florida
$881K -$294K -10,154 -24%
SO
128
STRS Ohio
Ohio
$865K +$98.5K +3,400 +12%
Teacher Retirement System of Texas
129
Teacher Retirement System of Texas
Texas
$823K -$101K -3,495 -10%
Los Angeles Capital Management
130
Los Angeles Capital Management
California
$811K +$334K +11,531 +62%
Zurich Cantonal Bank
131
Zurich Cantonal Bank
Switzerland
$787K -$6.95K -240 -0.8%
Canada Life
132
Canada Life
Manitoba, Canada
$762K +$5.27K +182 +0.6%
DekaBank Deutsche Girozentrale
133
DekaBank Deutsche Girozentrale
Germany
$737K
FG
134
Formula Growth
Quebec, Canada
$730K
LPL Financial
135
LPL Financial
California
$724K +$10.9K +376 +1%
SSA
136
Schonfeld Strategic Advisors
New York
$720K -$874K -30,176 -53%
GC
137
Guggenheim Capital
Illinois
$669K +$46.5K +1,605 +7%
HSBC Holdings
138
HSBC Holdings
United Kingdom
$660K +$77.5K +2,677 +12%
Handelsbanken Fonder
139
Handelsbanken Fonder
Sweden
$649K -$63.7K -2,200 -8%
SF
140
Synovus Financial
Georgia
$647K +$38.7K +1,337 +6%
BEI
141
Benjamin Edwards Inc
Missouri
$638K -$64.4K -2,222 -9%
Cerity Partners
142
Cerity Partners
New York
$633K +$325K +11,205 +92%
PA
143
Profund Advisors
Maryland
$624K -$9.5K -328 -1%
ASRS
144
Arizona State Retirement System
Arizona
$615K +$16.6K +572 +3%
PNC Financial Services Group
145
PNC Financial Services Group
Pennsylvania
$614K +$25.1K +865 +4%
HA
146
Huntleigh Advisors
Missouri
$590K +$25.4K +876 +4%
DTL
147
Dynamic Technology Lab
Singapore
$581K +$623K +21,500 New
VOYA Investment Management
148
VOYA Investment Management
Georgia
$572K -$587K -20,277 -49%
State Board of Administration of Florida Retirement System
149
State Board of Administration of Florida Retirement System
Florida
$562K
SG Americas Securities
150
SG Americas Securities
New York
$539K +$464K +16,032 +410%

VCYT Hedge Fund Activity: Q2 2025 in Review

278 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2025, worth a combined $2.31B — down 8.1% from $2.51B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of VCYT and 36 opened new positions — a net loss of 7 holders — while 103 trimmed existing stakes and 102 added.

The largest buyer was Artisan Partners, adding an estimated $31.3M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $40.1M sold.

  • 278 institutional investors held Veracyte (VCYT) as of Q2 2025, down from 287 in Q1 2025.
  • Funds reported $2.31B of Veracyte stock for Q2 2025, down 8.1% quarter-over-quarter.
  • 36 funds opened new Veracyte positions in Q2 2025 and 43 closed out, a net change of -7 holders.
  • The largest Veracyte buyer in Q2 2025 was Artisan Partners, an estimated $31.3M added.
  • The largest Veracyte seller in Q2 2025 was Driehaus Capital Management, an estimated $40.1M sold.

Based on aggregated 13F filings for Q2 2025.